Over 230 Babies Born With HIV in Gauteng Raises Concerns in South Africa





South Africa's Gauteng province is facing a concerning rise in the number of babies born with HIV. Over 230 infants have tested positive for the virus in the first half of 2024 alone, according to a YouTube video, prompting health officials and advocates to call for a renewed focus on preventative measures.

While effective medications have been available for over two decades to prevent mother-to-child transmission (MTCT) of HIV, these latest figures indicate a gap in implementation. Experts like Melani Langfelt, director of primary health care for the City of Tshwane's health department, point to the possibility of mothers not adhering to the prescribed antiretroviral treatment (ART) regimen as a potential reason.

While Gauteng isn't experiencing a technical increase in HIV prevalence among infants compared to targets, health authorities remain concerned. This highlights the ongoing challenge of ensuring effective utilization of available preventive measures.

The South African healthcare system routinely tests pregnant women for HIV and offers ART to minimize the risk of transmission to their babies. However, the recent data suggests a need to address potential factors hindering successful implementation of these programs.

WATCH VIDEO HERE


Focus on Prevention


The situation underscores the critical need for robust HIV prevention strategies. Here's a look at some key measures:

  • Increased HIV Testing: Widespread access to testing and promoting routine testing during pregnancy is crucial. Early diagnosis allows mothers to begin ART and significantly reduce the risk of transmission.
  • Safe Sex Practices: Consistent and correct condom use during vaginal, anal, and oral sex significantly reduces the risk of HIV transmission.
  • PrEP for At-Risk Individuals: Pre-exposure prophylaxis (PrEP) is a medication that can prevent HIV infection in people at high risk, including those with an HIV-positive partner.
  • Effective ART Programs: Ensuring pregnant women living with HIV have access to and adhere to ART is essential in preventing MTCT.
  • Safe Blood Products: Medical facilities must consistently use screened and safe blood products for transfusions and other procedures.
  • Harm Reduction Programs: For people who inject drugs, providing access to sterile needles and syringes through needle and syringe exchange programs can help prevent sharing contaminated needles, a potential transmission route.

By implementing these measures alongside educational campaigns and raising awareness, South Africa can strive towards a future where no child is born with HIV.